| Year |
Citation |
Score |
| 2018 |
Reddy DS, Yoshimura RF, Ramanathan G, Carver C, Johnstone TB, Hogenkamp DJ, Gee KW. Role of β-specific GABA-A receptor isoforms in the development of hippocampus kindling epileptogenesis. Epilepsy & Behavior : E&B. 82: 57-63. PMID 29587186 DOI: 10.1016/J.Yebeh.2018.02.020 |
0.796 |
|
| 2017 |
Yoshimura RF, Tran MB, Hogenkamp DJ, Ayala NL, Johnstone T, Dunnigan AJ, Gee TK, Gee KW. Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism-like behaviors in the BTBR mouse model. Neuropharmacology. PMID 28842344 DOI: 10.1016/J.Neuropharm.2017.08.029 |
0.773 |
|
| 2017 |
Gee KW, Olincy A, Kanner R, Johnson L, Hogenkamp D, Harris J, Tran M, Edmonds SA, Sauer W, Yoshimura R, Johnstone T, Freedman R. First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288. Journal of Psychopharmacology (Oxford, England). 269881117691590. PMID 28196430 DOI: 10.1177/0269881117691590 |
0.768 |
|
| 2015 |
Dasse O, Bilcer G, Putman D, Ng R, Gee K, Stevens KE, Tran M, Johnstone T, Yoshimura RF, Koelsch G, Kelly TA. APN0417: A potent and efficacious α7 nAChR positive allosteric modulator Biochemical Pharmacology. 97: 636. DOI: 10.1016/J.Bcp.2015.08.043 |
0.769 |
|
| 2015 |
Koelsch G, Detke MJ, Stevens KE, Meltzer LT, Terry AV, Callahan PM, Yoshimura RF, Bilcer G, Anderson PC, Ng J, Ng R, Kelly TA. APN1125: A clinical stage α7 nicotinic acetylcholine receptor partial agonist Biochemical Pharmacology. 97: 636. DOI: 10.1016/J.Bcp.2015.08.042 |
0.446 |
|
| 2014 |
Hogenkamp DJ, Tran MB, Yoshimura RF, Johnstone TB, Kanner R, Gee KW. Pharmacological profile of a 17β-heteroaryl-substituted neuroactive steroid. Psychopharmacology. 231: 3517-24. PMID 24682501 DOI: 10.1007/S00213-014-3494-5 |
0.735 |
|
| 2014 |
Yoshimura RF, Tran MB, Hogenkamp DJ, Johnstone TB, Xie JY, Porreca F, Gee KW. Limited central side effects of a β-subunit subtype-selective GABAA receptor allosteric modulator. Journal of Psychopharmacology (Oxford, England). 28: 472-8. PMID 24108410 DOI: 10.1177/0269881113507643 |
0.796 |
|
| 2014 |
Koelsch G, Meltzer LT, Yoshimura RF, Terry AV, Callahan PM, Bilcer G, Ng J, Ng R, Gee KW, Kelly TA. P4-373: APN1125: A NOVEL A7 NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONIST Alzheimer's & Dementia. 10: P925-P925. DOI: 10.1016/J.Jalz.2014.07.142 |
0.58 |
|
| 2013 |
Hogenkamp DJ, Ford-Hutchinson TA, Li WY, Whittemore ER, Yoshimura RF, Tran MB, Johnstone TB, Bascom GD, Rollins H, Lu L, Gee KW. Design, synthesis, and activity of a series of arylpyrid-3-ylmethanones as type I positive allosteric modulators of α7 nicotinic acetylcholine receptors. Journal of Medicinal Chemistry. 56: 8352-65. PMID 24098954 DOI: 10.1021/Jm400704G |
0.786 |
|
| 2011 |
Johnstone TB, Gu Z, Yoshimura RF, Villegier AS, Hogenkamp DJ, Whittemore ER, Huang JC, Tran MB, Belluzzi JD, Yakel JL, Gee KW. Allosteric modulation of related ligand-gated ion channels synergistically induces long-term potentiation in the hippocampus and enhances cognition. The Journal of Pharmacology and Experimental Therapeutics. 336: 908-15. PMID 21159751 DOI: 10.1124/Jpet.110.176255 |
0.776 |
|
| 2010 |
Gee KW, Tran MB, Hogenkamp DJ, Johnstone TB, Bagnera RE, Yoshimura RF, Huang JC, Belluzzi JD, Whittemore ER. Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia. The Journal of Pharmacology and Experimental Therapeutics. 332: 1040-53. PMID 19940102 DOI: 10.1124/Jpet.109.161885 |
0.662 |
|
| 2007 |
Yoshimura RF, Hogenkamp DJ, Li WY, Tran MB, Belluzzi JD, Whittemore ER, Leslie FM, Gee KW. Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-administration in rats. The Journal of Pharmacology and Experimental Therapeutics. 323: 907-15. PMID 17873105 DOI: 10.1124/Jpet.107.128751 |
0.655 |
|
| 2006 |
Wang J, Hogenkamp DJ, Tran M, Li WY, Yoshimura RF, Johnstone TB, Shen WC, Gee KW. Reversible lipidization for the oral delivery of leu-enkephalin. Journal of Drug Targeting. 14: 127-36. PMID 16753826 DOI: 10.1080/10611860600648221 |
0.718 |
|
| 2004 |
Johnstone TB, Hogenkamp DJ, Coyne L, Su J, Halliwell RF, Tran MB, Yoshimura RF, Li WY, Wang J, Gee KW. Modifying quinolone antibiotics yields new anxiolytics. Nature Medicine. 10: 31-2. PMID 14647497 DOI: 10.1038/Nm967 |
0.771 |
|
| Show low-probability matches. |